(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.57% NOK 175.00
@ NOK185.50
Utstedt: 15 apr 2024 @ 16:25
Avkastning: -5.66%
Forrige signal: apr 15 - 13:04
Forrige signal:
Avkastning: -3.64 %
Live Chart Being Loaded With Signals
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally...
Stats | |
---|---|
Dagens volum | 2 701.00 |
Gjennomsnittsvolum | 5 636.00 |
Markedsverdi | 3.20B |
EPS | NOK0 ( 2024-04-24 ) |
Last Dividend | NOK4.50 ( 2023-04-25 ) |
Next Dividend | NOK0 ( N/A ) |
P/E | 30.86 |
ATR14 | NOK5.50 (3.09%) |
Volum Korrelasjon
Medistim ASA Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
TECH.OL | 0.929 |
ANDF.OL | 0.927 |
KOMPL.OL | 0.926 |
ELIMP.OL | 0.915 |
ASA.OL | 0.913 |
QFUEL.OL | 0.909 |
AUTO.OL | 0.909 |
NEL.OL | 0.9 |
VEI.OL | 0.898 |
BONHR.OL | 0.896 |
10 Mest negative korrelasjoner | |
---|---|
ODL.OL | -0.917 |
HAFNI.OL | -0.906 |
EQNR.OL | -0.904 |
FROY.OL | -0.898 |
SBX.OL | -0.889 |
WWI.OL | -0.876 |
SNI.OL | -0.861 |
EIOF.OL | -0.857 |
AKRBP.OL | -0.857 |
REACH.OL | -0.855 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Medistim ASA Korrelasjon - Valuta/Råvare
Medistim ASA Økonomi
Annual | 2023 |
Omsetning: | NOK526.36M |
Bruttogevinst: | NOK227.83M (43.28 %) |
EPS: | NOK5.68 |
FY | 2023 |
Omsetning: | NOK526.36M |
Bruttogevinst: | NOK227.83M (43.28 %) |
EPS: | NOK5.68 |
FY | 2022 |
Omsetning: | NOK486.26M |
Bruttogevinst: | NOK379.78M (78.10 %) |
EPS: | NOK6.25 |
FY | 2021 |
Omsetning: | NOK417.82M |
Bruttogevinst: | NOK320.70M (76.76 %) |
EPS: | NOK4.99 |
Financial Reports:
No articles found.
Medistim ASA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK4.50 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | NOK0.280 | 2005-04-29 |
Last Dividend | NOK4.50 | 2023-04-25 |
Next Dividend | NOK0 | N/A |
Payout Date | 2023-05-05 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | NOK28.30 | -- |
Avg. Dividend % Per Year | 0.96% | -- |
Score | 3.47 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.90 | |
Div. Directional Score | 7.98 | -- |
Year | Amount | Yield |
---|---|---|
2005 | NOK0.280 | 2.98% |
2006 | NOK0.270 | 2.05% |
2007 | NOK0.400 | 2.42% |
2008 | NOK0.500 | 2.63% |
2009 | NOK0.600 | 3.90% |
2010 | NOK0.150 | 0.64% |
2011 | NOK0.150 | 0.60% |
2012 | NOK1.000 | 4.35% |
2013 | NOK1.100 | 5.50% |
2014 | NOK0.800 | 3.48% |
2015 | NOK1.400 | 4.67% |
2016 | NOK1.650 | 3.06% |
2017 | NOK1.750 | 2.27% |
2018 | NOK2.00 | 2.78% |
2019 | NOK2.25 | 3.37% |
2020 | NOK2.75 | 1.42% |
2021 | NOK3.00 | 1.20% |
2022 | NOK3.75 | 0.96% |
2023 | NOK4.50 | 1.93% |
2024 | NOK0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ALNG.OL | Dividend King | 2023-11-27 | Quarterly | 2 | 6.60% | 7.04 |
OKEA.OL | Dividend Knight | 2023-12-01 | Quarterly | 3 | 5.65% | 6.86 |
SALM.OL | Dividend Knight | 2023-06-09 | Annually | 17 | 2.80% | 4.97 |
BWLPG.OL | Dividend Knight | 2023-11-17 | Quarterly | 11 | 1.68% | 4.46 |
ELK.OL | Dividend Knight | 2023-05-02 | Annually | 6 | 6.64% | 4.31 |
BWO.OL | Dividend Knight | 2023-11-20 | Quarterly | 14 | 0.87% | 3.96 |
ATEA.OL | Dividend Knight | 2023-11-20 | Annually | 16 | 2.97% | 3.45 |
HAFNI.OL | Dividend Knight | 2023-11-23 | Semi-Annually | 5 | 1.18% | 3.31 |
AKER.OL | Dividend Knight | 2023-11-07 | Semi-Annually | 20 | 2.99% | 3.13 |
AUSS.OL | Dividend Knight | 2023-05-26 | Annually | 17 | 3.23% | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.197 | 1.500 | 6.06 | 9.08 | [0 - 0.5] |
returnOnAssetsTTM | 0.205 | 1.200 | 3.16 | 3.79 | [0 - 0.3] |
returnOnEquityTTM | 0.272 | 1.500 | 8.09 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 4.15 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.68 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.632 | 1.500 | 2.04 | 3.07 | [0.2 - 2] |
debtRatioTTM | 0.0349 | -1.500 | 9.42 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 14.67 | 1.000 | 5.68 | 5.68 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.34 | 2.00 | 7.89 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.44 | 2.00 | 7.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0443 | -1.500 | 9.82 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.686 | 1.000 | 1.903 | 1.903 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.250 | 1.000 | 7.01 | 7.01 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 6.57 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.041 | 0.800 | 6.39 | 5.12 | [0.5 - 2] |
Total Score | 11.06 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 30.81 | 1.000 | 6.99 | 0 | [1 - 100] |
returnOnEquityTTM | 0.272 | 2.50 | 8.77 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.44 | 2.00 | 8.19 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.57 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.34 | 2.00 | 7.89 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.220 | 1.000 | 7.00 | 0 | [0.1 - 0.5] |
Total Score | 4.90 |
Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.